DURHAM, NC -- (MARKET WIRE) -- May 15, 2007 -- Serenex, Inc., an integrated oncology-focused drug discovery and development company, announced today the appointment of Judith C. Bryson Pharm.D. to the position of vice president, clinical development. Dr Bryson will be responsible for all aspects of clinical development and will serve as a member of the company’s senior management team.
